Aktis Oncology (AKTS) IPO deck
A clinical-stage oncology biotech developing next-generation targeted radiopharmaceuticals to safely deliver alpha-emitting therapies to a broader range of solid tumors.
A clinical-stage oncology biotech developing next-generation targeted radiopharmaceuticals to safely deliver alpha-emitting therapies to a broader range of solid tumors.
%20IPO%20deck){kind=link}